Question

Article+on+covid+19+with+heading

Answer 1

Answer:

In December 2019, a novel coronavirus called SARS-CoV-2 has resulted in the outbreak of a respiratory illness known as COVID-19. Karger Publishers supports research in this area by providing free access to relevant articles (listed below) and works with international organisations to support the sharing of relevant research and data, including supporting the WHO and the initiative from the White House Office of Science and Technology to make all relevant research and data immediately available in one place via PubMed Central (PMC). In addition, to enable fast access to research articles, we have signed the consensus statement by Wellcome about Sharing research data and findings relevant to the novel coronavirus (COVID-19) outbreak.

Answer 2

Explanation:

$\huge\boxed{\fcolorbox{red}{purple}{Answer!!}}$

In early April, researchers measured seroprevalence of antibodies to SARS-CoV-2 among residents in Santa Clara Country. Using their data, the team calculated COVID-19 prevalence estimates 50–85-fold more than the number of confirmed cases. This implies that the infection is much more widespread than indicated by the number of confirmed cases.

Covid-19 – navigating the uncharted

Fauci et al., 2020 – N. Engl. J. Med.

An editorial published in late March outlines the results from previous research concerning SARS-CoV-2, which have since been used to inform the response to the outbreak, including travel restrictions. As current studies continue to shed light on the characteristics of this virus, this article highlights the need to understand the pathogenesis of COVID-19 in order to navigate our responses in this unchartered arena.

Treatment of 5 critically ill patients with COVID-19 with convalescent plasma

Shen et al., 2020 – JAMA

A study conducted in Shenzhen (China) involved transfusing five critically ill COVID-19 patients with convalescent blood plasma in order to determine whether this was beneficial to their treatment. The researchers observed an improved clinical status in their patients as a result of the treatment but stated that these observations require further evaluation in clinical trials.

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study